Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.3656 versus placebo for alcohol use disorder
NL-OMON45553Phase 2Withdrawn
- Sponsor
- Bioprojet
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BP1.3656 in alcohol use disorder (AUD) (3 arms), sponsored by Bioprojet. Primary endpoint: Change in monthly heavy drinking days. Planned start Jun 2017; status: withdrawn.
02
Drugs
BP1.3656
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NL-OMON45553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45553.